Roflumilast 00904-7483-03
- Manufacturer
- Major Pharmaceuticals
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- May 22, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA208256
Need to source Roflumilast? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Roflumilast | 500 ug/1 |
Drug Class
Phosphodiesterase 4 Inhibitor [EPC]Phosphodiesterase 4 Inhibitor [EPC]Phosphodiesterase 4 Inhibitors [MoA]
Selected Package
00904-7483-03Selected30 TABLET in 1 BOTTLE (0904-7483-03)
Other packages for this product(1)
90 TABLET in 1 BOTTLE (0904-7483-89)